<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Utah Birth Defect Network (UBDN) collects population-based data for Utah on births from <z:hpo ids='HP_0000001'>all</z:hpo> resident women </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence of <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> and epidemiologic characteristics/outcomes were evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>Cases categorized as a <z:hpo ids='HP_0002652'>skeletal dysplasia</z:hpo> from <z:hpo ids='HP_0000001'>all</z:hpo> live births, <z:hpo ids='HP_0003826'>stillbirths</z:hpo>, and pregnancy terminations (TAB) between 1999 and 2008 were reviewed by three clinical geneticists </plain></SENT>
<SENT sid="3" pm="."><plain>After case review, 153 were included for analysis (88% live births, 3% <z:hpo ids='HP_0003826'>stillborn</z:hpo>, 9% TAB), and categorized by groupings defined by molecular, biochemical, and/or radiographic criteria as outlined in the 2010 Nosology and Classification of Genetic <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">Skeletal Disorders</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The overall prevalence for <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> was 3.0 per 10,000 births, and 20.0 per 10,000 <z:hpo ids='HP_0003826'>stillbirths</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The most common diagnostic groups were <z:e sem="disease" ids="C0029434" disease_type="Disease or Syndrome" abbrv="">osteogenesis imperfecta</z:e> (OI; n = 40; 0.79 per 10,000), thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 22; 0.43 per 10,000), <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> (n = 18; 0.35 per 10,000), and cleidocranial <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 6; 0.12 per 10,000) </plain></SENT>
<SENT sid="6" pm="."><plain>The most common groups based on the 2010 Nosology and Classification of Genetic <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">Skeletal Disorders</z:e> were the FGFR3 <z:mp ids='MP_0002657'>chondrodysplasia</z:mp> group (n = 41; 0.81 per 10,000), the OI/<z:mp ids='MP_0000063'>decreased bone density</z:mp> group (n = 40; 0.79 per 10,000), and the type 2 collagen group (n = 10; 0.2 per 10,000) </plain></SENT>
<SENT sid="7" pm="."><plain>Median age of postnatal diagnosis was 30 days (range 1-2,162) </plain></SENT>
<SENT sid="8" pm="."><plain>Of those deceased, 88% were prenatally suspected; of those alive 29% prenatally suspected </plain></SENT>
<SENT sid="9" pm="."><plain>Median age of <z:hpo ids='HP_0011420'>death</z:hpo> for live born individuals was 1 day (range 1-1,450 days) </plain></SENT>
<SENT sid="10" pm="."><plain>Previously reported prevalence rates vary, but our data provide a population-based approach not limited to the perinatal/neonatal period </plain></SENT>
<SENT sid="11" pm="."><plain>Understanding the range for survival within each group/diagnosis is beneficial for health care providers when counseling families </plain></SENT>
</text></document>